Intero Biosystems, a University of Michigan spinout, is making waves in the world of preclinical drug screening with their cutting-edge development of pluripotent stem cell-derived human miniature intestines. Their innovative technology promises to enhance early-stage drug testing, offering game-changing potential for the pharmaceutical industry.

This dynamic startup boasts an impressive list of accomplishments, including winning the miLSEA Pitch competition, opening their own independent lab, and securing three prestigious awards at the Michigan Business Challenge. These include the first-place Invention Track award, the Williamson Award for best engineer/MBA duo, and the Michigan Investment Challenge Award.

Looking ahead, Intero Biosystems continues to build momentum. They will present at the SXSW pitch competition and have been named finalists in the Rice Business Plan and Baylor New Venture Competitions. Additionally, they are in the midst of raising a pre-seed funding round to drive their mission forward.

Stories like these highlight the incredible work by our members—if you have news to share, we’d love to hear from you!